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Abstract
Background: Cutaneous metastasis from colorectal cancer after excision of the primary is a rare
occurrence and presents as cutaneous or subcutaneous nodules or as a rash commonly on the
anterior abdominal wall.
Case presentation: This is a case description of the management of a large fungating peristomal
cutaneous metastasis occurring 14 years after abdomino-perineal excision of the primary cancer.
The gross appearance initially suggested possibility of a true metachronous cancer with peristomal
spread. But histopathology of the resected specimen showed no colonic mucosal involvement
suggesting a true large cutaneous peristomal metastasis which has not been reported previously.
Literature review of presentation, management and prognosis of cutaneous metastasis from
colorectal cancer is described
Conclusion: Cutaneous metastasis following colorectal cancer resection is a well-recognised
entity though rare. Any unusual skin lesions especially on the abdominal wall skin, previous incision
scars or near the stoma should be biopsied early to rule out metastatic disease and systematic
work-up should be carried out to rule out any metachronous tumour or metastasis elsewhere in
the body.
Background
Cutaneous metastasis arising from colorectal malignancy
is a rare occurrence though well reported in literature. It is
a pointer to more widespread disease and usually indi-
cates a poor prognosis. Cutaneous metastasis can be the
presenting feature before the primary is diagnosed e.g. Sis-
ter Mary Joseph's nodules. They can also occur late after
the primary has been completely excised and can present
either as cutaneous rash or as subcutaneous nodules in
proximity to previous operative scars (abdominal or peri-
neal) or on the abdominal wall skin. This is an unusual
presentation of a large fungating peristomal metastasis
without any visceral involvement following abdomino-
perineal excision of a large T4 rectal cancer done 14 years
earlier.
Case presentation
A 61 year old lady was referred by the General Practitioner
as an emergency with a rapidly enlarging fungating mass
around her end-colostomy site. She had undergone an
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abdomino-perineal resection 14 years earlier for a Duke's
B rectal cancer. She had initially presented 14 years ago
with features of large bowel obstruction secondary to a
large rectal tumour. She had a defunctioning loop colos-
tomy constructed followed by adjuvant radiotherapy to
shrink the rectal tumour. At the time of the Abdomino-
perineal Resection, the tumour was adherent to the uterus
and she underwent hysterectomy with bilateral salpingo-
oopherectomy with partial vaginectomy to achieve full
surgical clearance. Histopathology of the original speci-
men revealed a T4 tumour with clear margins and no
lymph node involvement. No chemotherapy was given
after surgery.
She was lost to follow-up till she re-presented with this
peristomal mass. On clinical examination, she was found
to have a large 12 × 12 cms mass, eroding through the skin
in two areas, around the stoma, which appeared stenosed
but was functioning normally (Figure 1). There was no
history of loss of weight or appetite and the mass had
reportedly grown rapidly over a period of four weeks.
Trucut biopsy of the mass gave a diagnosis of adenocarci-
noma of colonic origin. Her serum CEA level was elevated
at 11.1 μg/L and her Haemoglobin was 9.9 g/dL (MCV –
82.8 fL). A staging CT scan of the chest, abdomen and pel-
vis demonstrated the 8 × 5 cms mass adjacent to the stoma
lying mainly in the subcutaneous fat with no invasion
into the muscles (Figure 2). There was no evidence of any
metastatic disease elsewhere.
At operation, the mass and the adjacent colostomy were
excised wide with generous margins and placed in a bowel
bag to avoid any tumour seeding (figure 3). A midline
Laparotomy was then performed. There was no evidence
of any intra-abdominal metastasis and a curative resection
of the mass with en bloc completion colectomy was per-
formed (Figure 4). The large 17 × 14 cms defect was cov-
ered with V.A.C® (KCI) dressing and an end ileostomy was
Clinical photograph showing peristomal cutaneous metastasis Figure 1
Clinical photograph showing peristomal cutaneous metasta-
sis.
CT scan of the mass, showing abdominal wall metastasis Figure 2
CT scan of the mass, showing abdominal wall metastasis.
Wide local excision of the mass with the stoma Figure 3
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constructed in the right iliac fossa (figure 5). She made an
uneventful post-operative recovery and after 19 days of
V.A.C® therapy a meshed split skin graft was harvested
from the anterior thigh and used to resurface the abdom-
inal wound.
The histopathology of the specimen showed complete
excision of the subcutaneous mass with clear margins (fig-
ure 6) and the microscopic examination showed exten-
sively necrotic and inflamed, well-differentiated colonic
adenocarcinoma invading into the subcutaneous fat.
There was no mucosal abnormality in the resected colon
and there was no evidence of lymphovascular invasion.
She was offered adjuvant chemotherapy but she declined
it.
Discussion
Stomal recurrence following abdomino-perineal resection
of a rectal cancer would indicate a metachronous tumour
arising from the colonic mucosa. This is well reported in
world literature with at least 10 cases described [1-3]. This
may present as a stomal stricture, peristomal rash or ulcer-
ation, or as a peristomal mass. The time of presentation of
the metachronous tumour can be 4 to 30 years following
the original resection of the primary [1]. In the present
case, initially the clinical and CT appearances seemed to
fit in with a metachronous tumour, explaining the reason
for doing a completion colectomy and wide local excision
of the mass en bloc. However, the histopathology of the
specimen clearly shows normal colonic mucosa from cae-
cum to the stoma with only some ulceration at the stoma
site, precluding a metachronous tumour. This suggests a
true isolated metastasis to the peristomal skin, as the pre-
operative staging CT scan and the operative findings did
not show any evidence of other visceral metastasis.
The incidence of cutaneous metastases associated with all
cancers in both sexes is 0.7 to 9.0% [4]. In Lookingbill's
study of metastatic disease, the incidence of cutaneous
Completed excision wound with end ileostomy Figure 4
Completed excision wound with end ileostomy.
V.A.C® dressing on the open wound Figure 5
V.A.C® dressing on the open wound. Specimen after resection Figure 6
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metastasis in colorectal cancer was 4.4% [5]. Colorectal
metastases usually occur within 2 years of the primary
tumour resection and the common organs involved are
liver, peritoneum, pelvis, lung and bone in decreasing fre-
quency [6]. The clinicopathological risk factors for skin
metastasis are primary tumours that extend transmurally
through the wall of the colon or rectum, lymph node
metastases at presentation and perforated primary
tumour [7]. The commonest site of cutaneous metastasis
in colorectal cancer is the abdominal wall skin [6]. They
can arise in previous surgical scars (abdominal or peri-
neal) including colostomy reversal scar [2]. Rarely this
may occur in the skin of the lower limbs, face or back
[8,9]. The gross appearance of skin metastasis is usually of
small subcutaneous nodules, which are under 5 cms in
size, or as superficial cutaneous papules. It can present
rarely as an inflammatory rash which can be confused
with primary skin conditions [10,11].
Rarely colorectal metastasis may present as a large cutane-
ous or subcutaneous mass (> 5 cms). Alexandrescu et al
described 2 cases of large cutaneous and subcutaneous
metastases (11 cms and 5 cms) presenting in the abdom-
inal incision scars occurring 5 and 3 years respectively
after the primary tumour resection [12]. At the time of
reporting, the patient had survived for 22 and 12 months
respectively after wide local excision, without any other
metastatic involvement. Tan et al. described inflammatory
subcutaneous mass > 10 cms diameter appearing 22
months after primary resection, growing in size rapidly on
the scapular region within a documented period of 1
month duration [13]. This was successfully excised but no
information is available regarding the survival period.
Greenberg et al reported a case of peristomal erythema,
ulceration and induration appearing 6 months after
abdomino-perineal resection which on shave biopsy
turned out to be metastatic disease and a tiny primary
focus was found in the resected stump suggesting a true
synchronous tumour (< 1 year of primary resection) with
peristomal cutaneous metastasis [14].
Our case is unique due to the size (> 10 cms), location
(proximity to colostomy) and the time interval after resec-
tion of the primary (14 years). One of the possible mech-
anisms of spread of the tumour from the rectum to the
colostomy site could be via the lymphatic channels in
continuity with the loop colostomy that was constructed
prior to the patient undergoing the abdomino-perineal
excision. The second possibility is for micro-metastasis
left behind in lymph nodes along the inferior mesenteric
artery pedicle at the time of the abdomino-perineal resec-
tion. No specific mention was made in the initial opera-
tive notes of the curative or palliative intent of the
operation, and if a high tie was carried out (ligation the
inferior mesenteric artery flush with the aorta). This could
lead to lymph node metastasis developing at a later date
and could break through the skin presenting as a fungat-
ing mass. Histopathology did not reveal any evidence of
lymphoid tissue either in the resected mass or in the
remaining mesocolon of the completion colectomy to
support these possible lymphatic routes. The third possi-
ble mechanism is by iatrogenic implantation of the color-
ectal cancer cells at the time of initial surgery. This is a well
recognised problem and can present as metastatic recur-
rence in the midline incisions, perineal wounds, port sites
and drain sites following surgery. The incidence of wound
recurrence following open resection of colorectal cancer
was 0.8% to 1.5% in two large series of total of 3314
patients and 80% of these recurrences occurred within 12
months of the initial surgery [15,16]. The trauma of sur-
gery results in an inflammatory response which has been
shown to enhance the successful implantation of exfoli-
ated tumour cells in animal models. This may be a conse-
quence of enhanced tumor cell adhesion or transient
generalised immune suppression following surgery [17].
Tumour cell implantation could be the likely cause of
metastatic recurrence in our case.
The survival period following diagnosis of cutaneous
colorectal metastasis is 1 to 34 months. Lookingbill et al
found a mean survival period of 18 months in 18 patients
with skin metastases from colorectal carcinoma [5]. In the
series by Saeed et al. the survival period was 2 to 4.5
months in 5 cases of colonic cancer [18]. There are case
reports of patients surviving 4 years and 10.5 years follow-
ing treatment of isolated metastsasis [6]. The prognosis of
cutaneous metastasis would depend on the presence of
concomitant metastasis elsewhere at the time of diagnosis
and also on the surgical clearance achieved if found to be
true isolated metastasis. Tumour differentiation and lym-
phovascular invasion are also important factors in altering
the prognosis.
Wide local excision of the cutaneous or subcutaneous
lesion is the preferred treatment option in isolated
lesions. There are no clear guidelines for the optimum
chemotherapeutic regimen for a non-resectable recur-
rence of colorectal cancer. Focal radiotherapy has been
tried for cutaneous rash with poor response [8,11]. The
chemotherapy treatments described include 5-fluorour-
acil [19], capecitabine [11], irinotecan [6], oxaliplatin
[6,11,14] and cisplatin [19]. The chemotherapy drugs
have evolved from a single agent 5-Fluorouracil (5-FU) as
the first line agent to the current combination of drugs.
The combination of irinotecan to bolus 5-FU has
increased median survival from 12 months to 14.8
months [20]. The combination of infusional 5-FU and
leucovorin(LV) with oxaliplatin (FOLFOX) [21] or infu-
sional 5-FU/LV with irinotecan (FOLFIRI) [22] has
increased this survival figure to above 20 months. TreatingWorld Journal of Surgical Oncology 2008, 6:96 http://www.wjso.com/content/6/1/96
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patients sequentially with FOLFIRI followed by FOLFOX,
or with FOLFOX followed by FOLFIRI, has increased the
median survival times to 21.5 months and 20.6 months,
respectively [23]. Our patient was offered chemotherapy
but she declined it. We intend to follow her up at 6
monthly intervals with CEA level estimations and cross
sectional liver imaging.
Conclusion
Cutaneous metastasis following colorectal cancer resec-
tion is a well-recognised entity though rare. Any unusual
skin lesions especially on the abdominal wall skin, previ-
ous incision scars or near the stoma should be biopsied
early to rule out metastatic disease and systematic work-
up should be carried out to rule out any metachronous
tumour or metastasis elsewhere in the body. For isolated
cutaneous or subcutaneous metastasis, wide local excision
would be the preferred surgical option followed by adju-
vant chemotherapy depending on the histopathological
status.
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